{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:20:14Z","timestamp":1778916014193,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ygyno.2021.01.005","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T10:49:14Z","timestamp":1610621354000},"page":"297-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses"],"prefix":"10.1016","volume":"161","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Locke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana I.","family":"Tergas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Befano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard D.","family":"Strickler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.01.005_bb0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0010","series-title":"New Guidelines on Screening and Treatment for Cervical Cancer (http:\/\/www.who.int\/reproductivehealth\/topics\/cancers\/en\/index.html)","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1200\/JGO.2016.006577","article-title":"Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline","volume":"3","author":"Jeronimo","year":"2016","journal-title":"J. Glob. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.005_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ijc.32885","article-title":"Key issues that need to be considered while revising the current annex of the European council recommendation (2003) on cancer screening","volume":"147","author":"Ponti","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228042","article-title":"Implementation of Australia\u2019s renewed cervical screening program: preparedness of general practitioners and nurses","volume":"15","author":"Sultana","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ygyno.2021.01.005_bb0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical-cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0035","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/ijc.31212","article-title":"Initial results of population based cervical-cancer screening program using HPV testing in one million Turkish women","volume":"142","author":"Gultekin","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0045","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"10","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0060","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jama.2017.19872","article-title":"Screening for cervical cancer in primary care: a decision analysis for the US preventive services task force","volume":"320","author":"Kim","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.ygyno.2021.01.005_bb0070","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/cncy.22266","article-title":"Sensitivity of cervico-vaginal cytology in endometrial carcinoma: a systematic review and meta-analysis","volume":"128","author":"Frias-Gomez","year":"2020","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0075","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","article-title":"Type I and II endometrial cancers: have they different risk factors?","volume":"31","author":"Setiawan","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0080","article-title":"Endometrial Cancer","author":"Casey","year":"2020","journal-title":"StatPearls [Internet]"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0085","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000493132","article-title":"Ten-year comparison study of type 1 and 2 endometrial cancers: risk factors and outcomes","volume":"84","author":"Feinberg","year":"2019","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0090","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2013.02.023","article-title":"Etiologic heterogeneity in endometrial cancer: evidence from a gynecologic oncology group trial","volume":"129","author":"Brinton","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0095","first-page":"1851","article-title":"Factors associated with type I and type II endometrial cancer","volume":"21","author":"Felix","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0100","series-title":"Cervical Cancer Screening at a Cross Roads","author":"Levenson","year":"2016"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0105","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda system: terminology for reporting results of cervical cytology","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/01.AOG.0000109426.82624.f8","article-title":"Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening","volume":"103","author":"Wright","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0b013e318159408b","article-title":"2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"Wright","year":"2007","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0125","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical-cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0130","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000438975","article-title":"The diagnostic value of routine Papanicolaou smears for detecting endometrial cancers: an update","volume":"59","author":"Lai","year":"2015","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/ajcp\/aqv085","article-title":"The value of Papanicolaou tests in the diagnosis of endometrial carcinoma: a large study cohort from an Academic Medical Center","volume":"145","author":"Serdy","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0145","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cncr.22770","article-title":"Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system","volume":"111","author":"Thrall","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0150","first-page":"913","article-title":"Age influences the clinical significance of atypical glandular cells on cytology","volume":"35","author":"Asciutto","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-017070","article-title":"Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study","volume":"7","author":"Norman","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2021.01.005_bb0160","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/dc.24268","article-title":"Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?","volume":"47","author":"Harbhajanka","year":"2019","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1006\/gyno.1999.5360","article-title":"Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal pap smears","volume":"73","author":"Kim","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0170","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000325117","article-title":"Clinical significance of atypical glandular cells in conventional pap smears in a large, high-risk U.S. west coast minority population","volume":"53","author":"Zhao","year":"2009","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0175","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2009.05.019","article-title":"Histologic follow-up results in 662 patients with pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods","volume":"114","author":"Zhao","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cncy.21791","article-title":"Significance of high-risk HPV detection in women with atypical glandular cells on pap testing: analysis of 1857 cases from an academic institution","volume":"125","author":"Patadji","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0185","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncy.21724","article-title":"Clinical significance of atypical glandular cells in pap tests: an analysis of more than 3000 cases at a large academic women\u2019s center","volume":"124","author":"Pradhan","year":"2016","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7314\/APJCP.2016.17.1.135","article-title":"High-grade cervical histopathology in women with atypical glandular cell cytology","volume":"17","author":"Watcharanon","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/dc.23777","article-title":"Clinicopathological significance of atypical glandular cells on cervicovaginal pap smears","volume":"45","author":"Kim","year":"2017","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0200","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000493000","article-title":"Glandular cell abnormalities on SurePath preparations: a retrospective review with cytology-histology correlations","volume":"62","author":"Fischer","year":"2018","journal-title":"Acta Cytol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0205","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.AOG.0000202401.29145.68","article-title":"Clinical significance of atypical glandular cells on cervical cytology","volume":"107","author":"Schnatz","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0210","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/jamainternmed.2018.2820","article-title":"Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta-analysis","volume":"178","author":"Clarke","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0215","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8793","article-title":"Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers","volume":"10","author":"Wang","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004952","article-title":"Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers","volume":"5","author":"Kinde","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ygyno.2021.01.005_bb0225","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dc.23649","article-title":"Image analysis and multi-layer perceptron artificial neural networks for the discrimination between benign and malignant endometrial lesions","volume":"45","author":"Makris","year":"2017","journal-title":"Diagn. Cytopathol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:54:49Z","timestamp":1758772489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821000524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0090825821000524"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.005","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}